Loncar Cancer Immunotherapy ETF (CNCR)

EXCHANGE TRADED CONCEPTS, LLC., ANNOUNCES COMPLETION OF FUND REORGANIZATION

Exchange Traded Concepts, LLC, adviser to the Range Cancer Therapeutics ETF (CNCR) and the Loncar China BioPharma ETF (CHNA) is pleased to announce the completion of the reorganization of CHNA into CNCR following the close of business on October 20, 2023.